Impact of Acute Myocardial Infarction Type on Prognosis in Female Patients With Cardiogenic Shock

Abstract

There are limited data about mid-term prognosis according to acute myocardial infarction (AMI) type in female patients with AMI complicated by cardiogenic shock (CS). In this study, we evaluated the impact of AMI type on prognosis in female patients who underwent percutaneous coronary intervention (PCI) for AMI complicated by CS. A total of 184 female patients who underwent PCI for AMI complicated by CS were enrolled from 12 centers in the Republic of Korea. Patients were divided into 2 groups according to AMI type: the ST-segment elevation myocardial infarction (n=114) and the non-ST-segment elevation myocardial infarction (n=70) group. Primary outcome was a major adverse cardiac event (MACE) (defined as a composite of cardiac death, myocardial infarction, or repeat revascularization). Propensity-score matching analysis was performed to reduce selection bias and potential confounding factors. During 12-month follow-up, a total of 73 MACEs occurred (ST-segment elevation myocardial infarction group, 47 [41.2%] vs non-ST-segment elevation myocardial infarction group, 26 [37.1%], p=0.643). Multivariate analysis revealed no significant difference in the incidence of MACE at 12months between the 2 groups (adjusted hazard ratio 1.16, 95% confidence interval 0.70 to 2.37, p=0.646). After propensity-score matching, the incidence of MACE at 12months remained similar between the 2 groups (hazard ratio 1.31, 95% confidence interval 0.69 to 2.52, p=0.413). The similarity in MACEs between the 2 groups was consistent across a variety of subgroups. In conclusion, after adjusting for baseline differences, AMI clinical type did not appear to increase the risk of MACEs at 12months in female patients who underwent emergency PCI for AMI complicated by CS.